Yifan Pharmaceutical financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
¥245.06M ¥269.31M ¥347.91M ¥764.74M ¥479.92M ¥405.99M ¥379.88M ¥495.73M ¥644.19M ¥1.16B ¥1.68B ¥2.43B ¥3.50B ¥4.37B ¥4.63B ¥5.19B ¥5.40B ¥4.41B ¥3.84B ¥4.07B ¥0.00M
GM % Gross Margin %
32.99% 29.92% 35.29% 63.97% 41.64% 33.40% 26.14% -10.97% 22.79% 31.23% 39.93% 39.97% 50.43% 57.09% 44.04% 45.84% 46.31% 41.16% 48.30% 47.42% 0.00%
OM Operating Margin
16.92% 14.37% 7.54% 48.73% 15.72% 9.90% -6.04% -39.04% 3.22% 13.34% 18.07% 15.69% 26.73% 36.30% 20.58% 20.54% 18.77% 5.96% 4.35% 0.51% 0.00%
EPS Earnings Per Share
¥0.00 ¥0.05 ¥-0.34 ¥-0.41 ¥-0.09 ¥0.05 ¥0.00
Div. Dividends
¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.10 ¥0.05 ¥0.00 ¥0.00 ¥0.00 ¥0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
477.75m 477.75m 477.75m 477.75m 477.75m 551.05m 551.05m 551.05m 551.05m 551.05m 1100.8m 1100.8m 1100.8m 1206.97m 1206.97m 1051.2m 1234.68m 1234.11m 1226.02m 0m 1216.39m
OCF Operating Cash Flow
¥0.00M ¥24.12M ¥32.62M ¥248.71M ¥83.31M ¥58.59M ¥-33.82M ¥-52.82M ¥29.88M ¥34.32M ¥139.74M ¥401.96M ¥855.85M ¥1.13B ¥1.17B ¥937.24M ¥1.11B ¥301.23M ¥472.07M ¥348.58M ¥0.00M
FCF Free Cash Flow
¥0.00M ¥-34.51M ¥-25.00M ¥76.65M ¥-39.15M ¥-92.68M ¥-233.14M ¥-152.56M ¥-37.76M ¥9.72M ¥50.57M ¥184.81M ¥568.35M ¥646.87M ¥441.69M ¥71.17M ¥392.80M ¥-270.51M ¥-70.20M ¥-155.51M ¥0.00M
FCFS Free Cash Flow Per Share
¥0.00 ¥-0.07 ¥-0.06 ¥0.16 ¥-0.08 ¥-0.18 ¥-0.42 ¥-0.28 ¥-0.07 ¥0.02 ¥0.07 ¥0.17 ¥0.52 ¥0.57 ¥0.37 ¥0.06 ¥0.32 ¥-0.22 ¥-0.06 ¥-0.13 ¥0.00